chartexchange

EVO
Evotec SE
stockNASDAQADR

At CloseOct 2, 2026
1.60USD-2.736%(-0.05)52,035
Pre-marketOct 1, 2026 8:05:30 AM EDT
1.725USD+4.863%(+0.08)
Loading…
Loading…
570.40M
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Hamburg, Hamburg, Germany
Previous Close
$1.65
Beta
1.46
52-Week High
$4.27 2025-10-27
52-Week Low
$1.50 2026-09-21
SMA 50
$1.83
SMA 200
$2.70
Avg. Vol 10D
145,585
Avg. Vol 30D
124,778
Avg. Vol 90D
77,817
Relative Vol
0.42
355.39M
336.88M
15.8300%
745
EVO Profile

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

EVO Performance
PeriodPriceDateChangeBeta
1W1.592026-09-28+0.94%-7.303
1M1.862026-09-04-13.71%-0.221
3M2.922026-07-06-45.03%0.702
6M2.622026-04-06-38.74%1.489
1Y4.012025-10-03-59.98%1.461
2Y3.432024-10-04-53.21%—
5Y22.002021-11-04-92.70%1.158
EVO Stock Summary

Evotec SE (NASDAQ:EVO) stock price today is $1.61, and today's volume is 52,035. EVO is down 2.432% today. The 30 day average volume is 124,778. EVO market cap is $570.40M with 355.39M shares outstanding.